Otoferlin Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Otoferlin monoclonal antibodies for investigating auditory function. Otoferlin Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Otoferlin is a calcium-binding protein essential for the release of neurotransmitters in the inner ear, playing a pivotal role in sound transduction and auditory signaling. Mutations in the Otoferlin gene are linked to non-syndromic hearing loss, highlighting its significance in auditory health and development. Research utilizing Otoferlin monoclonal antibodies enables detailed examination of hearing mechanisms at the molecular level. Scientists can explore the relationship between Otoferlin expression patterns and various hearing disorders. Understanding Otoferlin's role through molecular studies may reveal new approaches for addressing hearing impairments. Investigating Otoferlin's interactions with other proteins provides insights into synaptic function and neurotransmitter release. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of auditory neuroscience and developing potential therapeutic strategies for hearing disorders.